SkinHealth Systems Inc. Earnings Per Share (Basic)
SkinHealth Systems Inc. (SKIN) reported Earnings Per Share (Basic) of -$0.02 per share for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:EarningsPerShareBasic · last filed 2026-08-06
- SkinHealth Systems Inc. earnings per share, basic for the quarter ending 2026-06-30 was -$0.02, a 112.50% decline year-over-year.
- SkinHealth Systems Inc. earnings per share, basic for the quarter ending 2026-03-31 was -$0.05.
- SkinHealth Systems Inc. earnings per share, basic for the quarter ending 2025-12-31 was -$0.06.
- SkinHealth Systems Inc. earnings per share, basic for the quarter ending 2025-09-30 was -$0.09.
- SkinHealth Systems Inc. earnings per share, basic for fiscal 2025 was -$0.08.
- SkinHealth Systems Inc. earnings per share, basic for fiscal 2024 was -$0.23.
- SkinHealth Systems Inc. earnings per share, basic for fiscal 2023 was -$0.76, a 353.33% decline from fiscal 2022.
- SkinHealth Systems Inc. earnings per share, basic for fiscal 2022 was $0.30.
| Period end | Earnings Per Share, Basic 3 month | Earnings Per Share, Basic 3 month as first filed | Earnings Per Share, Basic 6 month | Earnings Per Share, Basic 6 month as first filed | Earnings Per Share, Basic 9 month | Earnings Per Share, Basic 9 month as first filed | Earnings Per Share, Basic 12 month | Earnings Per Share, Basic 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | -$0.02 10-Q · filed 2026-08-06 | -$0.07 10-Q · filed 2026-08-06 | -$0.14 derived: net income ÷ weighted average shares · filed 2026-08-06 | -$0.22 derived: net income ÷ weighted average shares · filed 2026-08-06 | ||||
| 2026-03-31 | -$0.05 10-Q · filed 2026-05-07 | -$0.12 derived: net income ÷ weighted average shares · filed 2026-05-07 | -$0.20 derived: net income ÷ weighted average shares · filed 2026-05-07 | -$0.05 derived: net income ÷ weighted average shares · filed 2026-08-06 | ||||
| 2025-12-31 | -$0.06 derived: net income ÷ weighted average shares · filed 2026-03-12 | -$0.15 derived: net income ÷ weighted average shares · filed 2026-03-12 | $0.00 derived: net income ÷ weighted average shares · filed 2026-08-06 | -$0.08 10-K · filed 2026-03-12 | ||||
| 2025-09-30 | -$0.09 10-Q · filed 2025-11-06 | $0.07 derived: net income ÷ weighted average shares · filed 2026-08-06 | -$0.01 10-Q · filed 2025-11-06 | -$0.09 derived: net income ÷ weighted average shares · filed 2026-08-06 | ||||
| 2025-06-30 | $0.16 10-Q · filed 2026-08-06 | $0.08 10-Q · filed 2026-08-06 | -$0.01 derived: net income ÷ weighted average shares · filed 2026-08-06 | -$0.15 derived: net income ÷ weighted average shares · filed 2026-08-06 | ||||
| 2025-03-31 | -$0.08 10-Q · filed 2026-05-07 | -$0.16 derived: net income ÷ weighted average shares · filed 2026-05-07 | -$0.31 derived: net income ÷ weighted average shares · filed 2026-05-07 | -$0.31 derived: net income ÷ weighted average shares · filed 2026-05-07 | ||||
| 2024-12-31 | -$0.08 derived: net income ÷ weighted average shares · filed 2026-03-12 | -$0.23 derived: net income ÷ weighted average shares · filed 2026-03-12 | -$0.23 derived: net income ÷ weighted average shares · filed 2026-03-12 | -$0.23 10-K · filed 2026-03-12 | ||||
| 2024-09-30 | -$0.15 10-Q · filed 2025-11-06 | -$0.15 derived: net income ÷ weighted average shares · filed 2025-11-06 | -$0.15 10-Q · filed 2025-11-06 | -$0.23 derived: net income ÷ weighted average shares · filed 2026-03-12 | ||||
| 2024-06-30 | $0.00 10-Q · filed 2025-08-07 | $0.00 10-Q · filed 2025-08-07 | -$0.08 derived: net income ÷ weighted average shares · filed 2026-03-12 | -$0.66 derived: net income ÷ weighted average shares · filed 2026-03-12 | ||||
| 2024-03-31 | -$0.01 10-Q · filed 2025-05-08 | -$0.08 derived: net income ÷ weighted average shares · filed 2026-03-12 | -$0.65 derived: net income ÷ weighted average shares · filed 2026-03-12 | -$0.62 derived: net income ÷ weighted average shares · filed 2026-03-12 | ||||
| 2023-12-31 | -$0.07 derived: net income ÷ weighted average shares · filed 2026-03-12 | -$0.64 derived: net income ÷ weighted average shares · filed 2026-03-12 | -$0.61 derived: net income ÷ weighted average shares · filed 2026-03-12 | -$0.76 10-K · filed 2026-03-12 | ||||
| 2023-09-30 | -$0.56 10-Q · filed 2024-11-12 | -$0.53 derived: net income ÷ weighted average shares · filed 2024-11-12 | -$0.68 10-Q · filed 2024-11-12 | -$0.63 derived: net income ÷ weighted average shares · filed 2025-03-12 | ||||
| 2023-06-30 | $0.03 10-Q · filed 2024-08-08 | -$0.13 10-Q · filed 2024-08-08 | -$0.08 derived: net income ÷ weighted average shares · filed 2025-03-12 | -$0.08 derived: net income ÷ weighted average shares · filed 2025-03-12 | ||||
| 2023-03-31 | -$0.15 10-Q · filed 2024-05-09 | -$0.17 10-Q · filed 2023-05-10 | -$0.10 derived: net income ÷ weighted average shares · filed 2025-03-12 | -$0.10 derived: net income ÷ weighted average shares · filed 2025-03-12 | -$0.05 derived: net income ÷ weighted average shares · filed 2025-03-12 | |||
| 2022-12-31 | $0.05 derived: net income ÷ weighted average shares · filed 2025-03-12 | $0.04 derived: net income ÷ weighted average shares · filed 2025-03-12 | $0.09 derived: net income ÷ weighted average shares · filed 2025-03-12 | $0.30 10-K · filed 2025-03-12 | ||||
| 2022-09-30 | $0.00 10-Q · filed 2023-11-14 | $0.04 derived: net income ÷ weighted average shares · filed 2023-11-14 | $0.25 10-Q · filed 2023-11-14 | $0.27 10-Q · filed 2022-11-09 | $0.11 derived: net income ÷ weighted average shares · filed 2024-03-12 | |||
| 2022-06-30 | $0.04 10-Q · filed 2023-08-09 | $0.05 10-Q · filed 2022-08-09 | $0.25 10-Q · filed 2023-08-09 | $0.27 10-Q · filed 2022-08-09 | $0.11 derived: net income ÷ weighted average shares · filed 2024-03-12 | -$1.37 derived: net income ÷ weighted average shares · filed 2024-03-12 | ||
| 2022-03-31 | $0.21 10-Q · filed 2023-05-10 | $0.22 10-Q · filed 2022-05-10 | $0.07 derived: net income ÷ weighted average shares · filed 2024-03-12 | -$1.43 derived: net income ÷ weighted average shares · filed 2024-03-12 | -$2.64 derived: net income ÷ weighted average shares · filed 2024-03-12 | |||
| 2021-12-31 | -$0.14 derived: net income ÷ weighted average shares · filed 2024-03-12 | -$1.69 derived: net income ÷ weighted average shares · filed 2024-03-12 | -$3.04 derived: net income ÷ weighted average shares · filed 2024-03-12 | -$3.71 10-K · filed 2024-03-12 | -$3.67 10-K · filed 2022-03-01 | |||
| 2021-09-30 | -$1.63 10-Q · filed 2022-11-09 | -$3.16 derived: net income ÷ weighted average shares · filed 2022-11-09 | -$4.10 10-Q · filed 2022-11-09 | |||||
| 2021-06-30 | -$1.52 10-Q · filed 2022-08-09 | -$2.24 10-Q · filed 2022-08-09 | ||||||
| 2021-03-31 | -$0.09 10-Q · filed 2022-05-10 | |||||||
| 2020-12-31 | $0.00 derived: net income ÷ weighted average shares · filed 2023-03-01 | -$0.85 10-K · filed 2023-03-01 | ||||||
| 2020-09-30 | -$0.06 10-Q · filed 2021-11-12 | -$0.64 10-Q · filed 2021-11-12 | ||||||
| 2020-06-30 | -$0.30 10-Q · filed 2021-08-13 | -$0.58 10-Q · filed 2021-08-13 | ||||||
| 2019-12-31 | -$0.05 10-K · filed 2022-03-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| LENSAR, Inc. (LNSR) | United States | $0.087B | 2.02 |
| Microbot Medical Inc. (MBOT) | $0.089B | -7.97 | |
| Pulmonx Corp (LUNG) | United States | $0.082B | -1.16 |
| RenovoRx, Inc. (RNXT) | United States | $0.076B | -3.62 |
| FRACTYL HEALTH, INC. (GUTS) | United States | $0.075B | -1.18 |
| CVRx, Inc. (CVRX) | United States | $0.067B | -2.62 |
| DarioHealth Corp. (DRIO) | $0.066B | -1.39 | |
| TELA Bio, Inc. (TELA) | United States | $0.057B | -0.82 |
| Xtant Medical Holdings, Inc. (XTNT) | United States | $0.053B | |
| Apyx Medical Corp (APYX) | United States | $0.120B | -21.85 |